◆ NeutralDVA

Why DaVita HealthCare (DVA) Outpaced the Stock Market Today

Zacks Investment Research·
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today

DaVita HealthCare (DVA) closed at $179.25, up 1.26% and outperforming the S&P 500. The kidney dialysis provider is projected to report 50.6% EPS growth and 3.23% revenue growth in the upcoming quarter, with full-year estimates showing 35.16% earnings growth. Trading at a Forward P/E of 12.15 (below industry average of 20.06) and a PEG ratio of 0.46, DVA holds a Zacks Rank #3 (Hold) rating.

Read Full Article at Zacks Investment Research →
← Back to Financial Intelligence